Samples

JS Johann Steiner
TF Thomas Frodl
KS Kolja Schiltz
HD Henrik Dobrowolny
RJ Roland Jacobs
BF Brisa S Fernandes
PG Paul C Guest
GM Gabriela Meyer-Lotz
KB Katrin Borucki
SB Sabine Bahn
BB Bernhard Bogerts
PF Peter Falkai
HB Hans-Gert Bernstein
ask Ask a question
Favorite

Specimens came from the blood bank at the Department of Psychiatry, University of Magdeburg, Germany,15–17 and were collected from sequentially admitted acutely ill psychotic inpatients (February 2008 to June 2018; n = 253). FEP patients (n = 129) were drug-naïve at baseline (T0) and non-first-episode Sz patients (n = 124) were unmedicated ≥6 weeks. Controls (n = 294; healthy blood donors and hospital staff and their relatives) came from the same collection period (see table 1).

Demographic Data

Note: Data presented as median (quartile 1; quartile 3; sample size). BMI, body mass index; CRP, C-reactive protein; FEP, first-episode psychosis; PANSS, Positive and Negative Syndrome Scale; Sz, schizophrenia; T0, acutely ill unmedicated; T6, after 6 weeks of treatment.

*P < .05, **P < .01, ***P < .001.

Exclusion criteria were cannabis consumption or other substance abuse, psychosis induced by other medical conditions, a history of immune disease or immunotherapy.16 Controls were screened for personal or family history of neuropsychiatric disorders using the Mini-International Neuropsychiatric Interview.18 Procedures were approved by the local institutional review board and written informed consent was obtained.

Blood analyses and psychopathological assessments (PANSS) were performed at baseline. Follow-up assessments after 6 weeks (T6) were available for 175 patients. The types and cumulative dosages of antipsychotic drugs taken from baseline to follow-up were documented and converted into chlorpromazine (CPZ) equivalents.19–21 A total of 163 subjects were medicated for 6 weeks after baseline assessment (olanzapine: n = 71; quetiapine: n = 17; risperidone: n = 45; aripiprazole: n = 15; typical antipsychotic drugs: n = 9; other drugs/combinations: n = 6). Blood samples were obtained from fasting subjects at 08:00 am and collected into BD Vacutainer tubes (Becton Dickinson). Ethylenediamine tetraacetic acid-blood tubes were used for determining differential blood counts within 1 h. Serum tubes were centrifuged at 1000g for 10 min after 2 h clotting. Supernatants were aliquoted and stored at −80°C.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A